Laura Stanbery
Impact in
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- PARP inhibition in cancer therapy
- CAR-T cell therapy research
Papers in
- Oncology 36
- Cancer Immunotherapy and Biomarkers 16
- PARP inhibition in cancer therapy 12
- CAR-T cell therapy research 9
- Co-authors
- John Nemunaitis (49 shared papers)Susan Morand (13 shared papers)Monika Devanaboyina (6 shared papers)Lance D. Dworkin (14 shared papers)Danae Hamouda (11 shared papers)Gerald M. Edelman (8 shared papers)Khalil Choucair (8 shared papers)Justin F. Creeden (8 shared papers)
- Journals
- Future Oncology (7 papers)Cancer Gene Therapy (4 papers)Oncology Reviews (3 papers)Gynecologic Oncology (3 papers)Vaccines (3 papers)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Laura Stanbery
51 papers receiving 1.1k citations
Laura Stanbery's Hit Papers
Peers
Comparison fields: 5 of 95
- Reproductive Medicine 177
- Oncology 557
- Cancer Research 242
- Immunology 273
- Molecular Biology 441
Countries citing papers authored by Laura Stanbery
This map shows the geographic impact of Laura Stanbery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Stanbery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Stanbery more than expected).
Fields of papers citing papers by Laura Stanbery
This network shows the impact of papers produced by Laura Stanbery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Stanbery. The network helps show where Laura Stanbery may publish in the future.
Co-authors
The 25 scholars most cited alongside Laura Stanbery, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Ovarian Cancer Immunotherapy and Personalized Medicine Hit paper breakdown → | 2021 | 236 |
| 2 | 2020 | 122 | |
| 3 | 2021 | 84 | |
| 4 | 2022 | 56 | |
| 5 | 2021 | 56 | |
| 6 | 2020 | 47 | |
| 7 | 2022 | 39 | |
| 8 | 2020 | 29 | |
| 9 | 2021 | 26 | |
| 10 | 2010 | 26 | |
| 11 | 2021 | 25 | |
| 12 | 2020 | 24 | |
| 13 | 2020 | 23 | |
| 14 | 2023 | 22 | |
| 15 | 2019 | 21 | |
| 16 | 2021 | 20 | |
| 17 | 2020 | 19 | |
| 18 | 2022 | 15 | |
| 19 | 2023 | 15 | |
| 20 | 2021 | 14 |
About Laura Stanbery
Laura Stanbery is a scholar working on Oncology, Molecular Biology, Immunology, Reproductive Medicine and Cancer Research, having authored 54 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (16 papers), PARP inhibition in cancer therapy (12 papers), Immunotherapy and Immune Responses (11 papers), Ovarian cancer diagnosis and treatment (11 papers), CAR-T cell therapy research (9 papers), Cancer Genomics and Diagnostics (7 papers), Immune Cell Function and Interaction (5 papers) and Lung Cancer Treatments and Mutations (5 papers). The work is most often cited by research in Reproductive Medicine (177 citations), Oncology (557 citations), Cancer Research (242 citations), Immunology (273 citations) and Molecular Biology (441 citations). Laura Stanbery has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include John Nemunaitis, Susan Morand, Monika Devanaboyina, Lance D. Dworkin, Danae Hamouda, Gerald M. Edelman, Khalil Choucair, Justin F. Creeden, Daniel J. Craig and Luisa Manning. Their work appears in journals such as Future Oncology, Cancer Gene Therapy, Oncology Reviews, Gynecologic Oncology and Vaccines.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.